BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2045427)

  • 1. Biocompatible controlled release polymers for delivery of polypeptides and growth factors.
    Langer R; Moses M
    J Cell Biochem; 1991 Apr; 45(4):340-5. PubMed ID: 2045427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery systems for angiogenesis stimulators and inhibitors.
    Langer R
    EXS; 1992; 61():327-30. PubMed ID: 1377552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
    Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
    J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research and application of drug controlled release technique in tissue engineering].
    Wang SG; Cai Q; Lü Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Sep; 15(5):280-5. PubMed ID: 11761854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of polymeric delivery systems for macromolecules.
    Langer R; Brem H; Tapper D
    J Biomed Mater Res; 1981 Mar; 15(2):267-77. PubMed ID: 7348718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-delivery systems for tissue engineering: a materials perspective.
    Vasita R; Katti DS
    Expert Rev Med Devices; 2006 Jan; 3(1):29-47. PubMed ID: 16359251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrices and scaffolds for protein delivery in tissue engineering.
    Tessmar JK; Göpferich AM
    Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained delivery of growth factors from methylidene malonate 2.1.2-based polymers.
    Désiré L; Mysiakine E; Bonnafous D; Couvreur P; Sagodira S; Breton P; Fattal E
    Biomaterials; 2006 Apr; 27(12):2609-20. PubMed ID: 16364430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances in the controlled release of growth factor related to blood vessel tissue engineering].
    Wu L; Yuan X; Yao K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):911-4. PubMed ID: 17002137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation.
    Chen S; Singh J
    Int J Pharm; 2008 Mar; 352(1-2):58-65. PubMed ID: 18036752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery.
    Omeis I; Neil JA; Murali R; Abrahams JM
    Neurosurgery; 2008 Dec; 63(6):1011-9; discussion 1019-21. PubMed ID: 19057314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the release of proteins/peptides via the pulmonary route.
    Shoyele SA
    Methods Mol Biol; 2008; 437():141-8. PubMed ID: 18369966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of biocompatible poly(organophosphazenes) aiming for local delivery of protein drugs.
    Seong JY; Jun YJ; Kim BM; Park YM; Sohn YS
    Int J Pharm; 2006 May; 314(1):90-6. PubMed ID: 16549280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.